Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cardlytics Inc shares valued at $86,155 were sold by DeSieno Alexis on Nov 15 ’24. At $3.43 per share, DeSieno Alexis sold 25,118 shares. The insider’s holdings dropped to 116,481 shares worth approximately $0.46 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DeSieno Alexis purchased 25,118 shares, netting a total of over 86,165 in proceeds.
Before that, Gupta Amit had sold 22,607 shares from its account. In a trade valued at $86,924, the Chief Executive Officer traded Cardlytics Inc shares for $3.85 each. Upon closing the transaction, the insider’s holdings decreased to 22,607 shares, worth approximately $0.71 million.
As published in their initiating research note from Evercore ISI on October 11, 2024, Cardlytics Inc [CDLX] has been an In-line and the price target has been revised to $4. Analysts at Northland Capital downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid August. As of August 15, 2024, BofA Securities has decreased its “Neutral” rating to a “an Underperform” for CDLX. Earlier on August 08, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for CDLX stock which previously was a “a Buy”.
Analyzing CDLX Stock Performance
During the last five days, there has been a surge of approximately 8.17%. Over the course of the year, Cardlytics Inc shares have dropped approximately -56.89%. Shares of the company reached a 52-week high of $20.52 on 03/25/24 and a 52-week low of $2.89 on 08/08/24. A 50-day SMA is recorded $3.76, while a 200-day SMA reached $7.53. Nevertheless, trading volume fell to 0.47 million shares from 0.55 million shares the previous day.
Support And Resistance Levels for Cardlytics Inc (CDLX)
According to the 24-hour chart, there is a support level at 3.85, which, if violated, would cause prices to drop to 3.74. In the upper region, resistance lies at 4.06. The next price resistance is at 4.16. RSI (Relative Strength Index) is 51.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 56.19%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.